European Heart Journal Advance Access originally published online on February 28, 2008
European Heart Journal 2008 29(7):843-845; doi:10.1093/eurheartj/ehn066
Polymorphisms and atrial fibrillation: sorting the wheat from the chaff
Cardiovascular Research Center and Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA 02114, USA
* Corresponding author. Tel: +1 617 726 4959, Fax: +1 617 726 2155. Email: pellinor{at}partners.org
This editorial refers to ‘The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG)’
by M.F. Sinner et al., on page 907
Footnotes
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
In the last 5 years, we have gained an increasing appreciation for the genetic contribution to atrial fibrillation (AF). While Mendelian families with AF have been reported, they have typically been considered rare. Studies from Framingham1 and Iceland2 have demonstrated a genetic basis for AF in the general population. Family members of those with AF have an odds ratios of 
1.8 for developing the arrhythmia. This risk is considerably greater for younger patients1,2 and those with lone AF.3
One approach to identify common genetic determinants of a disease in a population is to perform an association study between a single nucleotide polymorphism (SNP) and the condition of interest. Such a study can be performed using one to many hundreds of thousands of SNPs across the genome. In the case of AF, numerous prior associations have been reported between AF and variants in the cardiac sodium and potassium channels, gap junction proteins, and inflammatory markers, among others. However, the studies to date have generally been underpowered, have not been replicated, and have a low pre-test probability of the SNP actually causing AF.
Sinner et al. have described the relationship between the K897T SNP in KCNH2/HERG and AF in >1200 affected individuals and 2400 controls.4 Based on the well-known relationship between variation in KCNH2/HERG and ventricular repolarization, the authors hypothesized that this gene may also be associated with alterations in atrial repolarization, and thus AF. Starting with 40 SNPs across the KCNH2 gene, they determined the frequency of each SNP in 671 cases and 694 controls and found five associated with AF. These five SNPs were then analysed in an additional 531 cases with AF and 1781 control subjects, and one, the well-known K897T polymorphism, emerged. This SNP had an odds ratio of 1.25 [95% confidence interval (CI) 1.11–1.41, P = 3.3 x 10–4] with the 897K allele being associated with an increased risk of AF, while the 897T allele had a reduced risk. This association remained after correction for the age and sex of the subjects.
With such a large, well-powered cohort, these investigators have raised the standard for future association studies on AF. However, this study was subject to some limitations. It would have been interesting to know the relationship between AF and ventricular repolarization in this population; unfortunately electrocardiograms were unavailable from the control subjects. This study is also limited by the lack of information on other covariates associated with AF, such as congestive heart failure and hypertension. Further, all of the subjects in the study were of European descent so the results many not be applicable to other races and ethnicities. Finally, with an odds ratio of 1.25, this variant in KCNH2 has a relatively modest overall effect in the population, implying that additional genetic variants for AF remain to be identified.
What do we know of the K897T polymorphism? This SNP has a minor allele frequency of 23% in Caucasians and is therefore common in the general population. As summarized in Table 1, it has been extensively studied for its role in ventricular repolarization. In 2002, Pietila and colleagues described the association between the QT interval and K897T in 413 individuals. They found that the minor allele, 897T, was associated with QT prolongation but only in the subset of 187 women. The following year, Bezzina et al. reported the opposite, that 897T was associated with QT shortening in 1382 subjects and was more predictive in females. This result was replicated by investigators from the KORA study who found that 897T is associated with a 1.9 ms reduction in the QT interval per allele and with a greater decrease in women than men. Recently, a similar result was noted in the Framingham Heart Study, with a reduction in the corrected QT interval by 1.6 ms per 897T allele. Thus, while there is some inconsistency, on the whole the preponderance of epidemiological data supports the association between the QT shortening effect and the 897T allele.
|
The results from these association studies create an apparent paradox. It has been well described in humans and in animal models of AF that electrical remodelling leads to shortening of the atrial action potential duration and that AF begets AF. There are also several reports of AF associated with short QT syndrome.5 Therefore, we would anticipate that AF would be associated with the 897T allele; however, it is the more common 897K allele that is associated with AF in the current study.
How then do we reconcile the current findings with the expectation that AF is usually associated with shortening of atrial refractory periods? Unfortunately, a clear answer does not emerge from functional studies of this polymorphism. Characterization of the 897T and K alleles in cell lines has been inconsistent, with multiple different effects observed from several experienced research groups.6–9 In most cases, investigators have seen a reduction in channel current density as well as subtle effects on channel activation, inactivation, and deactivation. The net effect of a reduction in channel activity would be expected to result in a prolongation of the action potential duration and QT interval. The observed differences between the clinical findings of a shortening of the QT interval and the expression studies might be due to subtle differences in experimental conditions, or the inherent limitations in heterologous expression systems.
It is interesting to note that there are a small number of cases where AF has been associated with prolonged repolarization. Two distinct gain-of-function mutations in KCNQ1 have been reported in a family and an individual with AF. While such an alteration would be expected to result in QT shortening, QT prolongation was noted in both cases.10,11 This discrepancy may reflect the failure of in vitro systems to recapitulate fully the intracardiac milieu of accessory subunits, signalling molecules, and other ion channels that interact to regulate repolarization. There is also the report of AF in an individual with a mutation of KCNA5 that encodes IKur. This loss-of-function mutation leads to prolongation of repolarization in atrial myocytes.12 Thus, we cannot discount the possibility that prolongation of atrial repolarization can under certain circumstances lead to AF, possibly through triggered activity.
In sum, these disparate clinical, electrophysiological, and genetic findings highlight our limited understanding of the determinants of atrial repolarization. The study of Sinner et al.4 provides a foundation for further investigation of the relationship between KCNH2 and AF, and will ultimately require replication at other centres. It also emphasizes that large cohorts with adequate power are necessary when examining genetic associations, a particularly important point given the emergence of genome-wide studies for AF and other cardiovascular traits.
Conflict of interest: none declared.
Footnotes
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
doi:10.1093/eurheartj/ehm619 
References
- Fox CS, Parise H, D'Agostino RB Sr, Lloyd-Jones DM, Vasan RS, Wang TJ, Levy D, Wolf PA, Benjamin EJ. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 291:2851–2855.
[Abstract/Free Full Text] - Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J (2006) 27:708–712.
[Abstract/Free Full Text] - Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA. Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 118:179–184.[CrossRef][Web of Science][Medline]
- Sinner MF, Pfeufer A, Akyol M, Beckmann B-M, Hinterseer M, Wacker A, Perz S, Sauter W, Illig T, Näbauer M, Schmitt C, Wichmann H-E, Schömig A, Steinbeck S, Meitinger T, Kääb S. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J (2008) 29:907–914. First published on January 25, 2008. doi:10.1093/eurheartj/ehm619.
[Abstract/Free Full Text] - Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol (2005) 16:394–396.[Web of Science][Medline]
- Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, Koopmann TT, Bhuiyan ZA, Wilders R, Mannens MM, Tan HL, Luft FC, Schunkert H, Wilde AA. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res (2003) 59:27–36.
[Abstract/Free Full Text] - Anson BD, Ackerman MJ, Tester DJ, Will ML, Delisle BP, Anderson CL, January CT. Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels. Am J Physiol Heart Circ Physiol (2004) 286:H2434–H2441.
[Abstract/Free Full Text] - Crotti L, Lundquist AL, Insolia R, Pedrazzini M, Ferrandi C, De Ferrari GM, Vicentini A, Yang P, Roden DM, George AL Jr, Schwartz PJ. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation (2005) 112:1251–1258.
[Abstract/Free Full Text] - Paavonen KJ, Chapman H, Laitinen PJ, Fodstad H, Piippo K, Swan H, Toivonen L, Viitasalo M, Kontula K, Pasternack M. Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG). Cardiovasc Res (2003) 59:603–611.
[Abstract/Free Full Text] - Lundby A, Ravn LS, Svendsen JH, Olesen SP, Schmitt N. KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm (2007) 4:1532–1541.[CrossRef][Medline]
- Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 299:251–254.
[Abstract/Free Full Text] - Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet (2006) 15:2185–2191.
[Abstract/Free Full Text] - Pietila E, Fodstad H, Niskasaari E, Laitinen PP, Swan H, Savolainen M, Kesaniemi YA, Kontula K, Huikuri HV. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol (2002) 40:511–514.
[Abstract/Free Full Text] - Pfeufer A, Jalilzadeh S, Perz S, Mueller JC, Hinterseer M, Illig T, Akyol M, Huth C, Schopfer-Wendels A, Kuch B, Steinbeck G, Holle R, Nabauer M, Wichmann HE, Meitinger T, Kaab S. Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res (2005) 96:693–701.
[Abstract/Free Full Text] - Newton-Cheh C, Guo CY, Larson MG, Musone SL, Surti A, Camargo AL, Drake JA, Benjamin EJ, Levy D, D'Agostino RB Sr, Hirschhorn JN, O'Donnell CJ. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation (2007) 116:1128–1136.
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG)
- Moritz F. Sinner, Arne Pfeufer, Mahmut Akyol, Britt-Maria Beckmann, Martin Hinterseer, Annette Wacker, Siegfried Perz, Wiebke Sauter, Thomas Illig, Michael Näbauer, Claus Schmitt, H.-Erich Wichmann, Albert Schömig, Gerhard Steinbeck, Thomas Meitinger, and Stefan Kääb
EHJ 2008 29: 907-914.[Abstract] [Full Text]
This article has been cited by other articles:
|
|
 |
|
  J.-P. Couderc, S. Kaab, M. Hinterseer, S. McNitt, X. Xia, A. Fossa, B. M. Beckmann, S. Polonsky, and W. Zareba Baseline Values and Sotalol-Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug-Induced Torsades de Pointes J. Clin. Pharmacol., January 1, 2009; 49(1): 6 - 16. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||